Inderjit Kaul

CIK: 0002095703

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)6 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

NERV

Minerva Neurosciences, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (6 total)

NERV
Minerva Neurosciences, Inc.
Nov 2, 2026
Award(A)
Stock Option (right to buy)
Direct
2.3K shares-
NERV
Minerva Neurosciences, Inc.
Aug 3, 2026
Award(A)
Stock Option (right to buy)
Direct
12.1K shares-
NERV
Minerva Neurosciences, Inc.
Jun 3, 2026
Award(A)
Stock Option (right to buy)
Direct
50K shares-
NERV
Minerva Neurosciences, Inc.
Mar 31, 2026
Award(A)
Stock Option (right to buy)
Direct
12.2K shares-
NERV
Minerva Neurosciences, Inc.
Dec 22, 2025
Award(A)
Stock Option (right to buy)
Direct
364.5K shares-
NERV
Minerva Neurosciences, Inc.
Nov 14, 2025
Award(A)
Stock Option (right to buy)
Direct
9.5K shares-

		Type	Shares	Price		Ownership
Nov 2, 2026	NERV Minerva Neurosciences, Inc.	Award(A) Stock Option (right to buy)	2,328	-	-	Direct
Aug 3, 2026	NERV Minerva Neurosciences, Inc.	Award(A) Stock Option (right to buy)	12,147	-	-	Direct
Jun 3, 2026	NERV Minerva Neurosciences, Inc.	Award(A) Stock Option (right to buy)	50,000	-	-	Direct
Mar 31, 2026	NERV Minerva Neurosciences, Inc.	Award(A) Stock Option (right to buy)	12,169	-	-	Direct
Dec 22, 2025	NERV Minerva Neurosciences, Inc.	Award(A) Stock Option (right to buy)	364,504	-	-	Direct
Nov 14, 2025	NERV Minerva Neurosciences, Inc.	Award(A) Stock Option (right to buy)	9,500	-	-	Direct

1-6 of 6 transactions

About Kaul Inderjit

Kaul Inderjit (SEC CIK 0002095703) files insider reports with the SEC as Director of Minerva Neurosciences, Inc. (NERV).

Signal8 holds 7 ownership filings by Kaul Inderjit (1 Form 3, 6 Form 4), filed between Nov 18, 2025 and Nov 3, 2026. Those filings report 6 transactions, the latest on Nov 2, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Kaul Inderjit's filings is in BURLINGTON, MA.

Recent filings by Kaul Inderjit

Nov 2, 2026: Grant or award of NERV derivative securities (Form 4, code A).
Aug 3, 2026: Grant or award of NERV derivative securities (Form 4, code A).
Jun 3, 2026: Grant or award of NERV derivative securities (Form 4, code A).
Mar 31, 2026: Grant or award of NERV derivative securities (Form 4, code A).
Dec 22, 2025: Grant or award of NERV derivative securities (Form 4, code A).

Other insiders filing for Minerva Neurosciences, Inc. (NERV)

Reilly Joseph H., Chief Operating Officer
Aliquo Anthony, Chief Accounting Officer
Ahlholm Frederick W, SVP, CFO and Secretary
Luthringer Remy, CEO
Laghrissi-Thode Fouzia, Director
Kupfer David, Director

How to read Form 4 transaction codes